PUBLICATION
The valence state of iron-based nanomaterials determines the ferroptosis potential in a zebrafish model
- Authors
- Zheng, N., Sun, X., Shi, Y., Chen, L., Wang, L., Cai, H., Han, C., Liao, T., Yang, C., Zuo, Z., He, C.
- ID
- ZDB-PUB-220920-30
- Date
- 2022
- Source
- The Science of the total environment 855: 158715 (Journal)
- Registered Authors
- He, Chengyong
- Keywords
- Ferroptosis, Fish, Nanomaterials, Valence state, iron
- MeSH Terms
-
- Animals
- Ferroptosis*
- Hypoxia
- Iron/toxicity
- Mammals
- Nanostructures*/toxicity
- Oxygen
- Zebrafish
- PubMed
- 36113792 Full text @ Sci. Total Environ.
Citation
Zheng, N., Sun, X., Shi, Y., Chen, L., Wang, L., Cai, H., Han, C., Liao, T., Yang, C., Zuo, Z., He, C. (2022) The valence state of iron-based nanomaterials determines the ferroptosis potential in a zebrafish model. The Science of the total environment. 855:158715.
Abstract
Many nanomaterials containing different valences of iron have been designed for applications in biomedicine, energy, catalyzers, nanoenzymes, and so on. However, the toxic effects of the valence state of iron in iron-based nanomaterials are still unclear. Here, three different-valence iron-based nanomaterials (nFe@Fe3O4, nFe3O4 and nFe2O3) were synthesized and exposed to zebrafish embryos and mammalian cardiomyocytes. All of them induced ferroptosis along with an increase in valence through iron overload and the Fenton reaction. Specifically, we exposed Tg (cmlc2:EGFP) zebrafish to the three iron-based nanomaterials and found that nFe@Fe3O4 treatments led to enlarged ventricles, while nFe3O4 and nFe2O3 increased atrial size, which was consistent with the results from hematoxylin-eosin staining and in situ hybridization. Moreover, we used ferroptosis inhibitors (ferrostatin-1 or deferoxamine) to treat zebrafish along with nanoparticles exposure and found that the cardiac developmental defects caused by nFe3O4 and nFe2O3, but not nFe@Fe3O4, could be completely rescued by ferroptosis inhibitors. We further found that nFe@Fe3O4, rather than nFe3O4 and nFe2O3, reduced the dissolved oxygen in the medium, which resulted in hypoxia and acceleration of heart tube formation and ventricular enlargement, and both were fully rescued by oxygen donors combined with ferroptosis inhibitors. Consistently, these findings were also observed in mammalian cardiomyocytes. In summary, our study demonstrates that the valence state of iron-based nanomaterials determines the ferroptosis potential. Our study also clarifies that high-valence iron-based nanomaterials induce an enlarged atrium via ferroptosis, while low-valence ones increase the ventricular size through both hypoxia and ferroptosis, which is helpful to understand the potential adverse effects of different valences of iron-based nanomaterials on environmental health and assure the responsible and sustainable development of nanotechnology.
Genes / Markers
Expression
Phenotype
Mutations / Transgenics
Human Disease / Model
Sequence Targeting Reagents
Fish
Orthology
Engineered Foreign Genes
Mapping